Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
FYI: Nearly 200 new exchange-traded products debuted last year, many of them ill-advised. But not all of the newcomers are duds. Here are four that look intriguing. Regards, Ted http://www.kiplinger.com/printstory.php?pid=13335
